A clinical study from January 2019 that assessed the effect of a dopamine precursor (levodopa), dopamine antagonist (risperidone), plus a placebo on reward responses to music – including the degree of pleasure experienced all through musical chills, as calculated by adjustments in electrodermal action together with subjective ratings – uncove